Dr. Yokoyama joined ReproCELL Inc. in 2004 as a general manager of business development and became Chief Executive Officer in 2005. He has been responsible for all aspects of new product management, alliance, and fund raising. He also participated in establishing a Stem Cell and Drug Discovery Institute in which human ES cell research is intensively carried out for the purpose of drug discovery and toxicity testing applications. From 1996 to 2004, he worked for McKinsey and Company Inc. as a management consultant and then for Sumitomo 3M, a subsidiary of 3M, to serve as a R&D leader of a new project. He received his Ph.D. in chemistry from Tokyo University in 1996.
Drug Discovery Technology using Human iPS Cells, Hepatocytes, Cardiomyocytes and Neurons
Friday, 3 February 2012 at 09:00
Add to Calendar ▼2012-02-03 09:00:002012-02-03 10:00:00Europe/LondonDrug Discovery Technology using Human iPS Cells, Hepatocytes, Cardiomyocytes and Neurons Stem Cells in San Diego, USASan Diego, USASELECTBIOenquiries@selectbiosciences.com
Human iPS cell technology for drug discovery, Cardiomyocytes for toxicity assay, Dopaminergic neuron for Parkinson disease, Hepatocytes for ADME testing.
Add to Calendar ▼2012-02-02 00:00:002012-02-03 00:00:00Europe/LondonStem CellsStem Cells in San Diego, USASan Diego, USASELECTBIOenquiries@selectbiosciences.com
Add to Calendar ▼2012-02-03 09:00:002012-02-03 10:00:00Europe/LondonDrug Discovery Technology using Human iPS Cells, Hepatocytes, Cardiomyocytes and Neurons Stem Cells in San Diego, USASan Diego, USASELECTBIOenquiries@selectbiosciences.com
